Vye Ventures

Bolt Graphics is a semiconductor startup focused on developing advanced graphics processors (GPUs) that prioritize performance and energy efficiency. The company addresses growing concerns regarding power consumption and environmental impact in the technology sector, particularly as hardware advancements have struggled to meet the escalating demands of industries such as architecture, engineering, film, advertising, gaming, and scientific research. Bolt Graphics offers a hardware-accelerated rendering platform equipped with a hardware ray tracing pipeline, which enables fast and flexible performance while minimizing costs. This innovation allows game developers, visual effects artists, and other creators to significantly reduce render times, thereby maximizing productivity and fostering creativity. The company's mission centers on rethinking traditional approaches to graphics processing, facilitating the creation of immersive experiences through enhanced rendering capabilities.

Melio is a healthcare company based in Santa Clara, California, specializing in blood testing technology aimed at detecting prevalent infections. The company has developed a comprehensive blood test platform that identifies common pathogens responsible for bloodstream infections. Utilizing a patented melting technique followed by detailed analysis, Melio's technology enables quick and accurate identification of blood-based pathogens. This innovation allows healthcare providers to deliver timely and targeted treatment, addressing the urgent need for effective therapies while also contributing to the fight against antibiotic resistance.

Oatmeal Health is a virtual clinic specializing in cancer care, enhanced by AI technology. It offers services such as lung cancer screening, risk assessments, diagnosis support, care navigation, and patient education. The company partners with community health centers, health systems, and imaging centers to provide high-quality, patient-centered care.

Lutroo Imaging is a pioneering company focused on revolutionizing pain diagnosis through its patented positron emission tomography (PET) radiotracer. By integrating artificial intelligence with molecular imaging diagnostics, Lutroo Imaging aims to provide healthcare professionals with an innovative system that allows for accurate visualization and quantification of chronic pain. This advancement seeks to enhance diagnostic processes, making them faster, more affordable, and more precise, ultimately improving the quality of life for the millions of adults worldwide who suffer from chronic pain.

Keyo AI Inc. is a technology company that specializes in developing a biometric identification platform, focusing on a contactless palm scanning system that enables secure access and transactions without the need for physical cards or keys. Founded in 2017 and headquartered in Palo Alto, California, Keyo's innovative solution uses near-infrared light to map the vein structure of a user's palm, generating a unique encrypted key from approximately 5 million reference points. This system enhances convenience for users by allowing them to make payments, unlock doors, and confirm identities while prioritizing privacy and data security. Keyo's offerings also include a platform for renting houses that eliminates brokerage fees and targets small-to-medium-sized landlords, further showcasing its commitment to leveraging technology for enhanced user experiences.

American Gene Technologies International Inc., established in 2007 and based in Rockville, Maryland, is a biotechnology company specializing in gene and cell therapeutics. It develops a lentiviral platform for diverse applications, including large and orphan indications, infectious diseases, immuno-oncology, and monogenic disorders. The company's portfolio includes a lead candidate for an HIV functional cure, a novel immuno-oncology approach for stimulating gamma-delta T cells, and a synthetic gene for treating Phenylketonuria (PKU). AGT aims to create long-term value for patients, society, investors, and donors by developing and testing cutting-edge gene therapies to cure some of humanity's worst diseases.

MD.ai is a developer of a comprehensive medical AI platform aimed at accelerating the application of artificial intelligence in healthcare, particularly in the field of medical imaging. The platform integrates machine learning with the expertise of human radiologists to interpret medical images, providing assessments and recommendations on significant findings. This collaboration enhances the efficiency and accuracy of medical diagnostics, ultimately improving patient care. MD.ai focuses on creating user-friendly software tools for clinicians, researchers, data scientists, and engineers, facilitating collaborative efforts in building impactful medical AI solutions. Through its commitment to rigorous real-world validation and guiding principles, MD.ai seeks to drive innovation and positively influence healthcare outcomes on a global scale.

Lutroo Imaging is a pioneering company focused on revolutionizing pain diagnosis through its patented positron emission tomography (PET) radiotracer. By integrating artificial intelligence with molecular imaging diagnostics, Lutroo Imaging aims to provide healthcare professionals with an innovative system that allows for accurate visualization and quantification of chronic pain. This advancement seeks to enhance diagnostic processes, making them faster, more affordable, and more precise, ultimately improving the quality of life for the millions of adults worldwide who suffer from chronic pain.

Loopie is a laundry delivery service that leverages a peer-to-peer managed marketplace model to offer a fast and cost-effective alternative to traditional wash and fold services. Founded in 2018 in Seattle, Loopie's innovative platform transforms idle washers and dryers into revenue-generating assets by connecting consumers and businesses with certified laundry providers. The service enables users to have their laundry picked up, washed, dried, folded, and delivered within hours, enhancing convenience and efficiency. Since its launch, Loopie has successfully expanded to six additional markets and has achieved over $1.25 million in early sales, supported by more than $2.25 million in early-stage and venture capital funding.